VEXTF - Vext Science, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
35,411
35,411
37,244
25,194
22,323
Cost of revenue
12,312
12,312
18,558
13,994
12,257
Gross profit
23,098
23,098
18,685
11,200
10,066
Operating expenses
Research development
-
-
150.064
158.685
112.962
Selling general and administrative
9,822
9,822
5,771
5,100
5,212
Total operating expenses
13,815
13,815
9,475
7,841
6,483
Operating income or loss
9,283
9,283
9,211
3,359
3,583
Interest expense
2,053
2,053
2,233
745.023
64.593
Total other income/expenses net
-644.786
-644.786
-897.438
-353.914
142.022
Income before tax
6,698
6,698
6,820
2,639
3,668
Income tax expense
-4,221
-4,221
1,833
514
874.905
Income from continuing operations
10,919
10,919
4,987
2,125
2,793
Net income
10,919
10,919
4,987
2,125
2,793
Net income available to common shareholders
10,919
10,919
4,987
2,125
2,793
Basic EPS
-
-
0.04
0.02
0.04
Diluted EPS
-
-
0.03
0.02
0.04
Basic average shares
-
-
136,713
92,770
78,901
Diluted average shares
-
-
146,414
93,528
79,258
EBITDA
-
15,185
12,341
5,521
4,566